PMID- 19459523 OWN - NLM STAT- MEDLINE DCOM- 20090623 LR - 20090522 IS - 0125-2208 (Print) IS - 0125-2208 (Linking) VI - 92 IP - 5 DP - 2009 May TI - Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis. PG - 632-7 AB - BACKGROUND: Despite the scanty data, proton pump inhibitors (PPI) are widely used for stress-related mucosal disease (SRMD) prophylaxis. There were few studies using PPI for SRMD prophylaxis but the results were conflicting, most probably due to inadequate sample size. The present meta-analysis aimed to determine the efficacy of PPI, as compared to histamine-2 receptor antagonists (H2RA) in the prevention of SRMD in critically-ill patients. MATERIAL AND METHOD: Meta-analysis of the randomized controlled trials comparing PPI versus H2RA for SRMD prophylaxis was performed. Outcomes of interest were incidences of clinically important gastrointestinal bleeding and nosocomial pneumonia. RESULTS: Three studies involving 569 patients were included in the meta-analysis. The overall incidence of clinically important bleeding was significantly lower in the PPI group (3.5%) as compared to H2RA (8%), odds ratio (OR) 0.42 (95% CI 0.20-0.91). The incidences of nosocomial pneumonia were not different (10.2% versus 10.1%, OR 1.02, 95% CI 0.59-1.75) between the two groups. CONCLUSION: The use of PPI for SRMD prophylaxis was associated with a significantly lower rate of clinically important bleeding than H2RA with similar rates of nosocomial pneumonia. FAU - Pongprasobchai, Supot AU - Pongprasobchai S AD - Division of Gastroenterology, Department of Internal Medicine, Siriraj Hospital, Bangkok, Thailand. tespb@mahidol.ac.th FAU - Kridkratoke, Samruay AU - Kridkratoke S FAU - Nopmaneejumruslers, Cherdchai AU - Nopmaneejumruslers C LA - eng PT - Comparative Study PT - Journal Article PT - Meta-Analysis PL - Thailand TA - J Med Assoc Thai JT - Journal of the Medical Association of Thailand = Chotmaihet thangphaet JID - 7507216 RN - 0 (Anti-Ulcer Agents) RN - 0 (Histamine H2 Antagonists) RN - 0 (Proton Pump Inhibitors) SB - IM MH - Anti-Ulcer Agents/*adverse effects MH - Confidence Intervals MH - Critical Illness MH - Cross Infection/etiology MH - Gastric Mucosa MH - Histamine H2 Antagonists/*adverse effects MH - Humans MH - Odds Ratio MH - Peptic Ulcer/*prevention & control MH - Pneumonia/etiology MH - Proton Pump Inhibitors/*adverse effects MH - Randomized Controlled Trials as Topic MH - Stomach Diseases/etiology MH - Stress, Physiological/*drug effects MH - Treatment Outcome EDAT- 2009/05/23 09:00 MHDA- 2009/06/24 09:00 CRDT- 2009/05/23 09:00 PHST- 2009/05/23 09:00 [entrez] PHST- 2009/05/23 09:00 [pubmed] PHST- 2009/06/24 09:00 [medline] PST - ppublish SO - J Med Assoc Thai. 2009 May;92(5):632-7.